Medsacpe Education

Mythbusting CGM

Separating Fact From Fiction in Your Practice

CME/CNE/CPE

FRIDAY, APRIL 26, 2024 | 3:00 pm - 3:40 pm ET
Supported by an independent educational grant from Abbott Diabetes Care.

overview

Studies have shown that with continuous glucose monitoring (CGM) use, patients experience improved glycemic control, less time in hypoglycemia, and improved quality of life. Join us for this live program, where our expert faculty will debunk 3 myths regarding barriers to the use of CGM in people who have type 2 diabetes. Faculty will also provide their tips and best practices that helped them successfully initiate and integrate CGM in their patients and practice.

faculty

MODERATOR

Eden M. Miller, DO

CEO

Diabetes and Obesity Care

Bend, Oregon

FACULTY

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES

Endocrine Physician Assistant

WVU Medicine Wheeling Hospital

Wellsburg, West Virginia

AGENDA

Welcome and Introduction

Eden M. Miller, DO

 


Myth: CGM is Only For People With Diabetes Using Multiple Daily Injections

Facts: Data Support the Use of CGM in an Expanded Patient Population

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES and Eden M. Miller, DO

 


Myth: Patients Don’t Want Technology

Facts: Patient Education Promotes Acceptance and Adherence to CGM

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES and Eden M. Miller, DO

 


Myth: CGM is Too Expensive

Facts: Cost Barriers Can Be Overcome

Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES and Eden M. Miller, DO

 


Closing Comments

Eden M. Miller, DO

 


Q&A

GOAL STATEMENT

The goal of this activity is for learners to be better able to improve ability to use continuous glucose monitoring (CGM) in practice.

TARGET AUDIENCE

This activity is intended for primary care physicians, diabetologists & endocrinologists, pediatricians, nurses, nurse practitioners, and pharmacists who manage patients with type 2 diabetes.

LEARNING OBJECTIVES

Upon completion of this activity, participants will:

Have increased knowledge regarding the

  • Data supporting use of CGM to improve management of type 2 diabetes and patient outcomes

Demonstrate greater confidence in their ability to

  • Use CGM to its full potential to positively impact patient outcomes

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

accreditation logo
medscape logo

For Physicians

Medscape, LLC designates this live activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses

Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs.

For Pharmacists

Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: JA0007105-0000-24-092-L01-P).

medscapelive
© 2024 MedscapeLIVE! All Rights Reserved | Terms of Service | Privacy Policy